impact factor, citescore
logo
 

Full Papers

 

Clinical utility of 18F-FDG PET/CT in patients with microscopic polyangiitis and interstitial lung disease: a retrospective cohort study


1, 2, 3, 4, 5, 6

 

  1. Division of Rheumatology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  2. Division of Rheumatology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Gyeonggi-do, Republic of Korea.
  3. Division of Rheumatology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  4. Division of Rheumatology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul; and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.
  5. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. alwoo@yuhs.ac
  6. Division of Rheumatology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul; and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea. sangwonlee@yuhs.ac

CER19296
Full Papers

purchase article

PMID: 41779594 [PubMed]

Received: 09/09/2025
Accepted : 03/11/2025
In Press: 02/03/2026

Abstract

OBJECTIVES:
We investigated the diagnostic and prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for interstitial lung disease (ILD) in patients with microscopic polyangiitis (MPA).
METHODS:
In this single-centre observational study, 61 patients with MPA who underwent high-resolution computed tomography (HRCT) and 18F-FDG PET/CT were included. ILD diagnosis was based on HRCT. 18F-FDG uptake in the lung parenchyma was assessed as a binary variable (present/absent). Diagnostic performance was evaluated by sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). The prognostic value was determined by Δ (1-year-baseline; positive=improvement) in forced vital capacity (FVC) and diffusing capacity of the lung for carbon monoxide (DLCO) using multivariable linear regression models.
RESULTS:
18F-FDG uptake showed high specificity and PPV (both 1.00) but limited sensitivity (0.63) and NPV (0.26) for ILD detection. Patients with 18F-FDG uptake demonstrated significantly greater Δ in FVC (β=8.26 [2.87–13.64], p=0.004) and DLCO (β=7.38 [0.06–14.69], p=0.048) compared with those without uptake. The prognostic value of 18F-FDG uptake was greater than that of the ILD pattern determined by HRCT (usual interstitial pneumonia [UIP] vs. non-UIP). While non-UIP patterns were associated with favourable Δ in FVC (β=8.02 [0.66–15.38], p=0.034), they were not associated with significant changes in DLCO (β=0.66 [-8.83–10.16], p=0.885).
CONCLUSIONS:
18F-FDG PET/CT demonstrated high specificity but limited sensitivity for detecting ILD in MPA, limiting its use as a screening tool. However, given its prognostic value, 18F-FDG PET/CT could be considered as a complementary imaging modality may aid prognostic stratification in MPA-associated ILD.

DOI: https://doi.org/10.55563/clinexprheumatol/2cy71q

Rheumatology Article